COMMUNIQUÉS West-GlobeNewswire

IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
01/07/2025
MOUNTAIN VIEW, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company that has focused on developing engineered IgM-based therapeutic antibodies, today announced that it [...]
Aviv Clinics Partners with Koterra to Expand Veteran Access to Lifesaving TBI and PTSD Treatment
01/07/2025
World-renowned brain treatment center is teaming up with a Tampa-based nonprofit to bring hyperbaric oxygen therapy treatments for Veterans across the country THE VILLAGES, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Every [...]
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
01/07/2025
REYKJAVIK, ICELAND and LONDON, UK (July 1, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma [...]
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
01/07/2025
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and [...]
AB Science : Résultats de l'Assemblée Générale Mixte du 30 juin 2025
01/07/2025
COMMUNIQUE DE PRESSE RESULTATS DE L’ASSEMBLEE GENERALE MIXTE DU 30 JUIN 2025 Paris, 1 er juillet 2025, 10h15 Les actionnaires de la société AB Science se sont réunis en Assemblée Générale Mixte, le lundi 30 juin 2025 à [...]
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
01/07/2025
Genitourinary Tumor Study Ongoing with Active Screening and Enrollment MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced that a total of [...]
atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression
01/07/2025
Study met its primary and all key secondary endpoints, and BPL-003 demonstrated rapid, robust and durable antidepressant effects with a single dose Both 8 mg and 12 mg single doses of BPL-003 showed statistically [...]
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
01/07/2025
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-approved oral therapies currently exist for this underserved [...]
CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité
01/07/2025
Communiqué de presse CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité Dijon, France 01 juillet 2025 (07h30 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), la société [...]
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application
01/07/2025
FDA 510(k) application submitted to allow marketing of the ARC-EX ® System for home use in the United States CE Mark application filed with notified body to enable commercialization of the ARC-EX System in the European [...]
UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss
01/07/2025
Rincell-1 addresses a multi $Bn global market opportunity where no disease modifying treatments currently exist Sheffield, July 01, 2025 (GLOBE NEWSWIRE) -- UK MHRA Approval Received for First-In-Human Trial of Rincell- [...]
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
01/07/2025
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants
01/07/2025
VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “ Company ”) announces that it will apply to the TSX Venture Exchange (the “ Exchange ”) to amend the terms of [...]
COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders
01/07/2025
TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a diversified portfolio of [...]
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities
01/07/2025
SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]
Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
01/07/2025
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug [...]
The Real Jerry Maguire Meets Prof. Mike Chan of European Wellness Biomedical Group to Discuss Sports Injuries and Concussion Recovery
30/06/2025
The man who inspired the multiple award-winning movie “Jerry Maguire” meets the pioneering stem cell scientist who is transforming regenerative medicine. Together, they may just hold the key to healing the silent [...]
Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters
30/06/2025
Contribution highlights leadership’s understanding of the importance AI will play in drug discovery WARREN, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) [...]
Human Appeal Announces First Summer UK Comedy Tour
30/06/2025
MANCHESTER, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) -- Following the roaring success of its annual winter Comedy Tour over the last decade, one of the UK’s leading humanitarian aid charities, Human Appeal, today [...]

Pages